人类碳酸无水酶调节器:过去,现在和未来
Simone Giovannuzzi1, Claudiu T Supuran1
1NEUROFARBA Department, Section of Pharmaceutical Science, University of Florence, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy.
Trends in pharmacological sciences
|August 7, 2025
概括
人类碳酸 anhydrases (hCAs) 是一种酶,具有超越玻璃眼的治疗潜力. 研究正在扩大它们对肥胖,炎症,瘤和神经退行症的应用.
科学领域:
- 生物化学 生物化学
- 酶学 是一种酶学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 人类碳酸无水酶 (hCAs) 是金属酶,历史上与眼睛和脏疾病有关.
- 目前的抗葡萄糖瘤和利尿药物向hCAs,但它们的治疗范围更广泛.
研究的目的:
- 审查对hCA调节器不断变化的理解.
- 为了突出显示hCA在各种病理中的失调.
- 讨论治疗发展的进展.
主要方法:
- 对hCA研究的文献综述.
- 分析hCA在各种疾病中的作用.
- 检查针对HCAs的治疗策略.
主要成果:
- 在肥胖,炎症,缺氧瘤,神经退行症和神经病变性疼痛方面,hCA调节器具有潜力.
- 对CA的调节失调与许多疾病有关.
- 在开发用于治疗应用的hCA调节器方面取得了重大进展.
结论:
- hCA调节剂代表了一种有前途的治疗途径,用于广泛的疾病.
- 对于新的治疗策略,需要对hCA调节进行进一步研究.
相关概念视频
Bicarbonate-Carbonic Acid Buffer
3.0K
The carbonic acid-bicarbonate buffer system is critical for maintaining the body's pH balance. It operates on the equilibrium:
3.0K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
509
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
509
Renal Regulation of Acid-Base Balance
704
Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
704
Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Respiratory Regulation of Acid-Base Balance
666
Respiratory compensation is a vital physiological process that stabilizes blood plasma pH by regulating the partial pressure of carbon dioxide (PCO2), a key determinant of pH levels. Most carbon dioxide in the blood dissolves and converts into carbonic acid (H2CO3). It dissociates into hydrogen ions (H+) and bicarbonate ions (HCO3⁻). There is also an inverse relationship between PCO2 and pH.
When carbon dioxide levels increase in the blood, more H+ and HCO3⁻ are...
When carbon dioxide levels increase in the blood, more H+ and HCO3⁻ are...
666
Cholinergic Antagonists: Pharmacokinetics
561
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
561


